University of Alberta
Also known as: Adrian Wagg | Alberta Diabetes Institute | Alberta Health Services, University of Alberta | Alberta Hospital Edmonton | Alberta Strategy for Patient Oriented Research Support Unit (AbSPORU) | Alberta University | AUIRC/University of Alberta | Bone and Joint Health SCN | Canadian VIGOUR Centre - University of Alberta | CK Hui Heart Centre, Royal Alexandra Hospital, Edmonton, Alberta. | Clinical Islet Transplant Program, University of Alberta | Cross Cancer Institute | Cross Cancer Institute, Alberta Health Services | Cross Cancer Institute at University of Alberta | Cross Cancer Institute, Edmonton AB | Cross Cancer Institute, Edmonton, AB Canada | Cross Cancer Institute, Edmonton, AB, Canada | Cross Cancer Institute, Edmonton Alberta Canada | Cross Cancer Institute, Edmonton, CA | Department of Psychiatry, University of Alberta | Dept. of Medicine, University of Alberta | Dept. of Pediatrics and Pharmacology, University of Alberta | Dina Kao | Division of Community Psychiatry, University of Alberta | Division of Plastic Surgery, Department of Surgery, University of Alberta | Faculty of Rehabilitation Medicine, University of Alberta | Grant Holder, Department of Oncology, University of Alberta | Harald Becher | Ian M. MacDonald | Janielee Williamson | Marcello Tonelli | McCaig Institiute of Bone and Joint Health | McCaig Institute for Bone and Joint Health | Professor of Endocrinology and Oncology, University of Alberta, Cross Cancer Institute | Professor, University of Alberta | Prof. Philip Halloran, Edmonton, Canada | Prof. Philip Halloran, Edmonton, Canada (sponsor) | Richard Fedorak | Robert Welsh | Staff Medical Oncologist, Cross Cancer Institute, Department of Medical Oncology, Edmonton, AB | Stollery Children's Hospital | Stollery Children's Hospital and the University of Alberta | Stollery Children's Hospital Edmonton | Stollery Children's Hospital Foundation | The Governors of the University of Alberta | Univeristy of Alberta | University Hospital Foundation | University of Alberta | University Of Alberta, Alberta, Canada | University of Alberta and Capital Health | University of Alberta/Capital Health | University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada | University of Alberta, Division of Gastroenterology, Department of Medicine, Edmonton, Alberta, Canada | University of Alberta, Edmonton | University of Alberta, Edmonton, Canada | University of Alberta Hospital, AB | University of Alberta Hospital, Edmonton, Canada | University of Alberta/Regional Palliatvie Care Program (Capital Health) | University of Alberta/Stollery Children's Hospital | Unviersity of Alberta | U of Alberta Co-Director,Perio Graduate Prog,Faculty of Medicine & Dentistry-Dentistry Dept | Women and Children's Health Research Institute, University of Alberta, Edmonton | Women and Children's Health Research Institute, Univesrity of Alberta | Xiaoli Fan
Highest phase reached
Phase 4
First clinical trial
Mar 1, 1994Last known activity
Mar 1, 2026
Timeline
1900s
- Jan 1, 1908
University of Alberta— Founded
Drugs by trial phase (352 distinct, 336 trials)
Phase 4 (61 own, 0 via acquisition)
Phase 3 (104 own, 0 via acquisition)
Phase 2 (115 own, 0 via acquisition)
Phase 1 (26 own, 0 via acquisition)
Other trials (46 own, 0 via acquisition)
Indications
Studied for
- Acute Kidney Injury
- Acute Lung Injury
- Adenocarcinoma
- Amyotrophic Lateral Sclerosis
- Anemia, Aplastic
- Anemia, Iron-Deficiency
- Anorexia
- Antiphospholipid Syndrome
- Apnea
- Arsenic Poisoning
- Ascites
- Asthma
- Atrial Fibrillation
- Attention Deficit Disorder with Hyperactivity
- Autistic Disorder
- Bone Diseases
- Bone Marrow Diseases
- Bone Neoplasms
- Brain Diseases
- Brain Injuries
- Brain Injuries, Traumatic
- Brain Ischemia
- Brain Neoplasms
- Breast Neoplasms
- Bronchiolitis
- Burning Mouth Syndrome
- Burns
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Cardio-Renal Syndrome
- Cardiovascular Diseases
- Carpal Tunnel Syndrome
- Cerebral Hemorrhage
- Cerebral Infarction
- Charcot-Marie-Tooth Disease
- Cholangitis
- Cholestasis
- Choroideremia
- Chromosome Aberrations
- Chromosome Disorders
- Cicatrix, Hypertrophic
- Cleft Palate
- Clostridium Infections
- Cognitive Dysfunction
- Colitis
- Colitis, Ulcerative
- Colorectal Neoplasms
- Communicable Diseases
- Congenital Hyperinsulinism
- Contracture
- Coronary Artery Disease
- Coronary Disease
- Coronavirus Infections
- Critical Illness
- Crohn Disease
- Depression
- Depressive Disorder
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Diarrhea
- Disease
- Dupuytren Contracture
- Dyspnea
- Emergencies
- Enterocolitis
- Enuresis
- Epilepsy
- Esophagitis
- Esophagitis, Peptic
- Fatigue
- Fibrosis
- Flushing
- Fragile X Syndrome
- Gastroenteritis
- Genetic Diseases, Inborn
- Genetic Diseases, X-Linked
- Glioblastoma
- Glioma
- Glomerulonephritis
- Glomerulonephritis, Membranous
- Graft vs Host Disease
- Headache
- Headache Disorders
- Headache Disorders, Secondary
- Head and Neck Neoplasms
- Heart Diseases
- Heart Failure
- Hemorrhage
- Hepatic Encephalopathy
- Hepatitis
- Hepatitis A
- Hepatitis, Autoimmune
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
Recent trials (50)
- NCT07301424Lead sponsorPhase 2Mar 1, 2026
- NCT06790589OfficialPhase 2Dec 31, 2025
- NCT07237282OfficialPhase 1Dec 1, 2025
- NCT07237282Lead sponsorPhase 1Dec 1, 2025
- NCT06972108Lead sponsorPhase 2Dec 1, 2025
- NCT07206277Lead sponsorN/ANov 1, 2025
- NCT07140484OfficialPhase 4Oct 6, 2025
- NCT07140484Lead sponsorPhase 4Oct 6, 2025
- NCT06785272CollaboratorPhase 3Sep 30, 2025
- NCT06819956Lead sponsorPhase 3Jul 31, 2025
- NCT06819956OfficialPhase 3Jul 31, 2025
- NCT06969573Lead sponsorPhase 2Jun 5, 2025
- NCT06969573OfficialPhase 2Jun 5, 2025
- NCT07015801CollaboratorN/AApr 15, 2025
- NCT06824077Lead sponsorEarly Phase 1Mar 1, 2025
Details
- Founded
- Edmonton, Alberta, CA Jan 1, 1908
- Last known activity
- Mar 1, 2026